Experts Develop Artificial Pancreas To Treat Patients Suffering from Type 1 Diabetes

An artificial pancreas, which when connected to a sensor under the skin can automatically check blood sugar levels and can treat type 1 diabetes.

Scientists have developed 'artificial pancreas,' a smartphone-sized device, which can treat type 1 diabetes and can be used safely for up to three months.

Daniel Walls, a schoolboy, was diagnosed with Type 1 diabetes and needed up to 10 finger-prick blood tests a day as well as regular insulin injections due to which he missed classes, Daily Express reports.

Blood Pressure Drugs can Lower Type 2 Diabetes Risk Whilst Asleep
Taking blood pressure medications at bedtime, reduces blood pressure (BP) whilst asleep and also halves the risk of developing type 2 diabetes.

The 12-year-old was temporarily fitted with the device and attended an entire term at school without having to worry about his health. Susan, his mother, said that the artificial pancreas could change my son's life and the lives of so many others. The device is connected to a sensor under the skin which automatically checks blood sugar levels.

There is a pump installed in the device which gives the correct dose of insulin when needed and blood sugar levels are charted on a tablet. According to experts, this was a significant step forward in the fight against the disease which has a devastating impact.

Lead researcher Dr Roman Hovorka said that the data clearly demonstrated the benefits of the artificial pancreas when used over several months, adding they had seen improved glucose control and reduced risk of unwanted low glucose levels.

University of Alberta Scientists Unveil Dimmer Switch To Delay the Onset Type-2 Diabetes
Researchers identified a new molecular pathway that manages the amount of insulin produced by the pancreatic cells when blood sugar increases.

Source-ANI

43-year-old Texas Woman with Type 1 Diabetes Now Off from Insulin Therapy After Islet Transplant
Doctors announced that a Texas woman who is part of the BioHub trial's pilot study is no longer using insulin injections following a minimally invasive transplant procedure.

Diabetes Drug 'Jardiance' May Reduce Risk Of Cardiovascular Deaths
Diabetics who take Jardiance were 35 percent less likely to be hospitalized for heart failure and 32 percent less likely to die of any cause.